2,2,2-trifluoro-1-(2-hydroxy-3,3-dimethylcyclopent-1-en-1-yl)ethan-1-one, 95%, 2.5g

Ala-Lys-OH�HCl, 99.0%, 250mg

8-Methyl-2-pyridin-4-yl-quinoline-4-carboxylic acid, 95.0%, 5g

N-1,3-benzothiazol-2-yl-2-chloroacetamide, 95.0%, 2.5g

2-o-Tolylquinoline-4-carboxylic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 50 m, 0.53 mm, 5.00 µm, 1 Piece(s)

Cyclobutyl 2-phenethyl ketone, 97.0%, 1g

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 95+%, 5g

6-Bromo-N-methylpyridin-3-amine, 97%, 5g

2-Amino-4,5-dimethoxybenzamide, 95.0%, 500mg

6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S)-, 98%, 5mg

4-(Tert-butoxymethyl)benzoic acid, 95+%, 5g

Ethyl 1-[6-chloro-4-(trifluoromethyl)pyridin-2-yl]piperidine-4-carboxylate, 95.0%, 1g